173 related articles for article (PubMed ID: 37033146)
1. Immune-mediated liver injury following COVID-19 vaccination.
Schinas G; Polyzou E; Dimakopoulou V; Tsoupra S; Gogos C; Akinosoglou K
World J Virol; 2023 Mar; 12(2):100-108. PubMed ID: 37033146
[TBL] [Abstract][Full Text] [Related]
2. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.
Efe C; Kulkarni AV; Terziroli Beretta-Piccoli B; Magro B; Stättermayer A; Cengiz M; Clayton-Chubb D; Lammert C; Bernsmeier C; Gül Ö; la Tijera FH; Anders M; Lytvyak E; Akın M; Purnak T; Liberal R; Peralta M; Ebik B; Duman S; Demir N; Balaban Y; Urzua Á; Contreras F; Venturelli MG; Bilgiç Y; Medina A; Girala M; Günşar F; Londoño MC; Androutsakos T; Kisch A; Yurci A; Güzelbulut F; Çağın YF; Avcı E; Akyıldız M; Dindar-Demiray EK; Harputluoğlu M; Kumar R; Satapathy SK; Mendizabal M; Silva M; Fagiuoli S; Roberts SK; Soylu NK; Idilman R; Yoshida EM; Montano-Loza AJ; Dalekos GN; Ridruejo E; Schiano TD; Wahlin S
Hepatology; 2022 Dec; 76(6):1576-1586. PubMed ID: 35567545
[TBL] [Abstract][Full Text] [Related]
3. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.
Mahroum N; Lavine N; Ohayon A; Seida R; Alwani A; Alrais M; Zoubi M; Bragazzi NL
Front Immunol; 2022; 13():872683. PubMed ID: 35865539
[TBL] [Abstract][Full Text] [Related]
5. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.
Lasagna A; Lenti MV; Cassaniti I; Sacchi P
Immunotherapy; 2022 Aug; 14(12):915-925. PubMed ID: 35694999
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.
Boettler T; Csernalabics B; Salié H; Luxenburger H; Wischer L; Salimi Alizei E; Zoldan K; Krimmel L; Bronsert P; Schwabenland M; Prinz M; Mogler C; Neumann-Haefelin C; Thimme R; Hofmann M; Bengsch B
J Hepatol; 2022 Sep; 77(3):653-659. PubMed ID: 35461912
[TBL] [Abstract][Full Text] [Related]
7. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers.
Borghi MO; Bombaci M; Bodio C; Lonati PA; Gobbini A; Lorenzo M; Torresani E; Dubini A; Bulgarelli I; Solari F; Pregnolato F; Bandera A; Gori A; Parati G; Abrignani S; Grifantini R; Meroni PL
Front Immunol; 2022; 13():930074. PubMed ID: 35911726
[TBL] [Abstract][Full Text] [Related]
8. Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients.
Lim SY; Yoon YI; Kim JY; Tak E; Song GW; Kim SH; Lee SG
Immune Netw; 2022 Jun; 22(3):e24. PubMed ID: 35799703
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
Kang SH; Kim MY; Cho MY; Baik SK
J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
[TBL] [Abstract][Full Text] [Related]
10. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.
Codoni G; Kirchner T; Engel B; Villamil AM; Efe C; Stättermayer AF; Weltzsch JP; Sebode M; Bernsmeier C; Lleo A; Gevers TJ; Kupčinskas L; Castiella A; Pinazo J; De Martin E; Bobis I; Sandahl TD; Pedica F; Invernizzi F; Del Poggio P; Bruns T; Kolev M; Semmo N; Bessone F; Giguet B; Poggi G; Ueno M; Jang H; Elpek GÖ; Soylu NK; Cerny A; Wedemeyer H; Vergani D; Mieli-Vergani G; Lucena MI; Andrade RJ; Zen Y; Taubert R; Terziroli Beretta-Piccoli B
JHEP Rep; 2023 Jan; 5(1):100605. PubMed ID: 36440259
[TBL] [Abstract][Full Text] [Related]
11. Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
Suntronwong N; Kanokudom S; Auphimai C; Assawakosri S; Thongmee T; Vichaiwattana P; Duangchinda T; Chantima W; Pakchotanon P; Chansaenroj J; Puenpa J; Nilyanimit P; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Mongkolsapaya J; Poovorawan Y
J Med Virol; 2022 Dec; 94(12):5713-5722. PubMed ID: 35924475
[TBL] [Abstract][Full Text] [Related]
12. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccination and liver disease.
Ozaka S; Kobayashi T; Mizukami K; Murakami K
World J Gastroenterol; 2022 Dec; 28(48):6791-6810. PubMed ID: 36632314
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of intradermal administration of fractional dose CoronaVac
Chatsiricharoenkul S; Niyomnaitham S; Posen HJ; Toh ZQ; Licciardi PV; Wongprompitak P; Duangchinda T; Pakchotanon P; Chantima W; Chokephaibulkit K
Front Immunol; 2022; 13():1010835. PubMed ID: 36268028
[TBL] [Abstract][Full Text] [Related]
15. Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.
Hollstein MM; Münsterkötter L; Schön MP; Bergmann A; Husar TM; Abratis A; Eidizadeh A; Schaffrinski M; Zachmann K; Schmitz A; Holsapple JS; Stanisz-Bogeski H; Schanz J; Fischer A; Groß U; Leha A; Zautner AE; Schnelle M; Erpenbeck L
Allergy; 2022 Aug; 77(8):2381-2392. PubMed ID: 35124800
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated liver injury following COVID-19 vaccination: A systematic review.
Roy A; Verma N; Singh S; Pradhan P; Taneja S; Singh M
Hepatol Commun; 2022 Sep; 6(9):2513-2522. PubMed ID: 35507736
[TBL] [Abstract][Full Text] [Related]
18. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines.
Ryan FJ; Norton TS; McCafferty C; Blake SJ; Stevens NE; James J; Eden GL; Tee YC; Benson SC; Masavuli MG; Yeow AEL; Abayasingam A; Agapiou D; Stevens H; Zecha J; Messina NL; Curtis N; Ignjatovic V; Monagle P; Tran H; McFadyen JD; Bull RA; Grubor-Bauk B; Lynn MA; Botten R; Barry SE; Lynn DJ
Cell Rep Med; 2023 Mar; 4(3):100971. PubMed ID: 36871558
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
